<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "cetuximab inj VIAL">
<dose><value>400</value>
<value>250</value>
<value>200</value>
<value>150</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>2 mg/mL</value>
</strength>
<frequency><value>ONCE</value>
</frequency>
<instruction><value>Administer dose undiluted over 2 hours.</value>
<value>Administer dose undiluted over 1 hour.</value>
</instruction>
<volume><value>50 mL</value>
</volume>
<units><value>mg/m2</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Head &amp; Neck Cancer. Loading dose: Cycle 1.</value>
<value>Head &amp; Neck Cancer. Maintenance dose.</value>
<value>Head &amp; Neck Cancer. Reduced Maintenance dose due to drug effects.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3354</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>FG</value>
</AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>